Form 4: SANUWAVE Health Director, James Tyler, Acquires Stock Options
SEC Form 4 Filing
James Tyler, a director of SANUWAVE Health, Inc., reports the acquisition of stock options on April 3, 2025.
Summary
- James Tyler, a director of SANUWAVE Health, Inc., filed a Form 4 with the SEC.
- The form reports a transaction that occurred on April 3, 2025.
- Tyler acquired 1,761 stock options with an exercise price of $29.80.
- The options are fully vested and expire on April 3, 2030.
- The underlying security is 1,761 shares of common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing of stock option acquisition. The acquisition of options by a director is generally viewed as a slightly positive sign.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The document does not contain any specific forward-looking statements or guidance.
Industry Context
This is a standard SEC filing related to insider transactions. It's common for directors and officers to receive stock options as part of their compensation.
Stakeholder Impact
- The acquisition of stock options by a director could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 04/03/2025 | Date of the stock option transaction. |
| 04/03/2030 | Expiration date of the stock options. |
| 04/07/2025 | Date of Form 4 filing. |
Keywords
SANUWAVE Health, Stock Options, Form 4, Director, James Tyler, Acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.